Revorf is a medical technology company that engages in the testing and discovery of diagnostic drugs for the healthcare industry.
Revorf has raised $42.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Revorf's investors include UntroD Capital, Nippon Venture Capital, i-nest capital, Sumitomo Corporation, Shinsei Corporate Investment.
Revorf is headquartered in Tokyo, Japan.
Revorf is a medical technology company that engages in the testing and discovery of diagnostic drugs for the healthcare industry.
Revorf is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Revorf — Funding & Investors." VCBacked, August 26, 2024, https://www.vcbacked.co/company/revorf. Accessed September 2, 2026.
VCBacked. (2024). Revorf — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/revorf
{{cite web |title=Revorf — Funding & Investors |url=https://www.vcbacked.co/company/revorf |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated